Symptomtext
patient had an ActHIB vaccine on 15Aug2023, however the vaccine had expired on 07Aug2023 with no reported adverse event; Initial information received on 15-Aug-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 4 years old female patient who had an HIB (PRP/T) vaccine [ACT-HIB] on 15aug2023, however the vaccine had expired on 07aug2023 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis A vaccine inact (Havrix); measles vaccine, mumps vaccine, rubella vaccine (MMR); pneumococcal vaccine conj 13V (CRM197) (Prevnar 13); varicella zoster vaccine live (OKA/MERCK) (Varivax); and diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3V (vero), tetanus vaccine toxoid (Kinrix) all for prophylactic vaccination (Immunisation). On 15-Aug-2023, the patient received 0.5 mL dose of expired suspect HIB (PRP/T) vaccine, powder and solvent for solution for injection (batch number: UJ735AAB; expiry date: 07-Aug-2023) via intramuscular route in the right thigh for immunization with no reported adverse event (expired product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event patient had an acthib vaccine on 15aug2023, however the vaccine had expired on 07aug2023 with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.